The clinical impact of Nintedanib and Pirfenidone on pulmonary circulation of interstitial pneumonia: A Hyogo-IP multicenter prospective observational study
Latest Information Update: 04 Mar 2021
At a glance
- Drugs Nintedanib (Primary) ; Pirfenidone (Primary)
- Indications Interstitial lung diseases
- Focus Therapeutic Use
- 04 Mar 2021 New trial record